Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Amortizatization of Intangibles of $570000.0 in Q1 2026, down 88.19% quarter-over-quarter from $4.8 million in Q4 2025, and down 70.16% on a YoY basis from $1.9 million in Q1 2025.
Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Pacira BioSciences' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $570000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 70.16% year-over-year to $570000.0; the TTM figure through Mar 2026 stood at $5.5 million (down 41.17% YoY), while the FY2025 annual figure was $4.9 million, down 33.61% from the prior year.
- Amortizatization of Intangibles was $570000.0 for Q1 2026 at Pacira BioSciences, down from $4.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $7.4 million in Q4 2024 to a low of $23000.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $675000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles slumped 96.44% in 2024, then jumped 7858.33% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $700000.0 in 2022, then surged by 449.71% to $3.8 million in 2023, then surged by 91.03% to $7.4 million in 2024, then sank by 34.35% to $4.8 million in 2025, then plunged by 88.19% to $570000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $570000.0 (Q1 2026), $4.8 million (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Pacira BioSciences | 944.76 Mn | 742.58 Mn | 140.96 Mn | 570,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 4.83 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 3.85 Mn |
| Dec 31, 2023 | 3.85 Mn |